Related Experiment Video
Updated: Aug 24, 2026

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
Published on: October 30, 2013
Expression of the cyclin-dependent kinase inhibitor p27 in transitional cell bladder cancers: is it a good predictor
Latife Doganay1, Semsi Altaner, Selcuk Bilgi
1Department of Pathology, Trakya University Medical Faculty, Edirne, Turkey. lcdoganay@hotmail.com
Objectives:
Progression of the cell cycle is regulated by the interactions of cyclins, cyclin dependent kinases (CDKs) and CDK inhibitors (CDKIs). p27 is a member of the universal cyclin-dependent kinase inhibitor family. The level of p27 protein expression decreases during tumor development and progression in some epithelial, lymphoid and endocrine tissues. It has been suggested that p27 is an independent prognostic factor in various human cancers. The prognostic value of p27 protein expression is not completely understood in bladder cancer yet.
Aims:
To investigate the immunohistochemical expression of p27 in transitional cell bladder cancers and its relationship with clinicopathological data, proliferating cell nuclear antigen (PCNA) and p53 oncoprotein immunoreactivity.
Methods:
The expression of p27 protein was immunohistochemically analyzed in paraffin-embedded specimens of 75 patients with transitional cell carcinoma of the bladder. p27 expression was compared with tumor grade, stage, growth pattern, disease-free survival, progression, PCNA and p53 immunoreactivity.
Results:
Expression of p27 was not significantly related to clinicopathologic parameters, disease-free survival, progression, PCNA and p53 immunoreactivity.
Conclusion:
The results indicate that p27 is not a good predictor for outcome of transitional cell carcinoma of the bladder.
Insights
p27 protein levels do not predict outcomes in bladder cancer. This study found no significant relationship between p27 expression and tumor characteristics or patient survival in transitional cell carcinoma.
Area of Science:
- Oncology
- Cell Biology
- Cancer Research
Background:
- Cell cycle progression is tightly regulated by cyclins, cyclin-dependent kinases (CDKs), and CDK inhibitors (CDKIs).
- p27 is a key cyclin-dependent kinase inhibitor (CDKI) whose expression often decreases in developing tumors.
- While p27 is a proposed prognostic factor in many cancers, its role in bladder cancer remains unclear.
Purpose of the Study:
- To examine the immunohistochemical expression of p27 in transitional cell bladder cancers.
- To correlate p27 expression with clinicopathological features, PCNA, and p53 immunoreactivity.
Main Methods:
- Immunohistochemistry was used to analyze p27 expression in 75 paraffin-embedded transitional cell carcinoma specimens.
- p27 expression was statistically compared with tumor grade, stage, growth pattern, disease-free survival, progression, PCNA, and p53.
Main Results:
- p27 protein expression showed no significant association with clinicopathological parameters.
- No significant correlation was found between p27 expression and disease-free survival, tumor progression, PCNA, or p53 immunoreactivity.
Conclusions:
- p27 protein expression is not a reliable predictor of outcomes in transitional cell carcinoma of the bladder.
- Further research may be needed to identify robust prognostic markers for bladder cancer.
Related Concept Videos
Inhibition of Cdk Activity
Abnormal Proliferation
Negative Regulator Molecules
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...